Biochips, a bio-microarray device, has been explored and developed extensively to enable large-scale genomic, proteomic, and functional genomic investigations. There are three types of biochips: DNA microarrays, protein microarrays, and microfluidic chips. A micro complete analysis system, also known as a lab-on-a-chip (LOC) system, is created by combining microarray and microfluidic technologies. Nanotechnology advancements have consistently lowered the size of the Biochips, lowering manufacturing costs and increasing high throughput capability.
This technology has the potential to be a critical and powerful tool for clinical research, diagnostics, drug development, toxicological investigations, and patient selection for clinical trials due to the benefits of low cost, high throughput, and miniaturization. DNA arrays are useful in a variety of genomic applications, including single nucleotide polymorphism (SNP) analysis, gene expression studies, disease classification, function prediction, pathway identification, new drug development, clinical diagnostics, and toxicology studies, due to their speed and high throughput. Protein chips, particularly functional microarrays, are used to investigate fundamental biological features such as protein interactions with other ligands such as proteins, peptides, lipids, and other compounds.
Read more @ https://latesthighlightscmi.blogspot.com/2021/12/biochips-what-are-they-for.html
0
Sign in to leave a comment.